| Hyewon Hyun, MD | |
|
330 Mount Auburn St, Cambridge, MA 02138-5502 | |
| (617) 499-5070 | |
| (617) 499-5138 |
| Full Name | Hyewon Hyun |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 330 Mount Auburn St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063587889 | NPI | - | NPPES |
| 0104612 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 203740 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
Reporting in the July 18 issue of The Journal of Experimental Medicine, a group of scientists in Wurzburg, Germany show that the lack of a blood clotting protein may protect against clogged arteries with no risk of excessive bleeding.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.
› Verified 5 days ago
| Entity Name | Massachusetts Institute Of Technology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346308723 PECOS PAC ID: 5597658666 Enrollment ID: O20040203000789 |
News Archive
Reporting in the July 18 issue of The Journal of Experimental Medicine, a group of scientists in Wurzburg, Germany show that the lack of a blood clotting protein may protect against clogged arteries with no risk of excessive bleeding.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.
› Verified 5 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346433257 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000142 |
News Archive
Reporting in the July 18 issue of The Journal of Experimental Medicine, a group of scientists in Wurzburg, Germany show that the lack of a blood clotting protein may protect against clogged arteries with no risk of excessive bleeding.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.
› Verified 5 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
Reporting in the July 18 issue of The Journal of Experimental Medicine, a group of scientists in Wurzburg, Germany show that the lack of a blood clotting protein may protect against clogged arteries with no risk of excessive bleeding.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.
› Verified 5 days ago
| Entity Name | Harbor Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124079561 PECOS PAC ID: 2466356209 Enrollment ID: O20040719000954 |
News Archive
Reporting in the July 18 issue of The Journal of Experimental Medicine, a group of scientists in Wurzburg, Germany show that the lack of a blood clotting protein may protect against clogged arteries with no risk of excessive bleeding.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.
› Verified 5 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Reporting in the July 18 issue of The Journal of Experimental Medicine, a group of scientists in Wurzburg, Germany show that the lack of a blood clotting protein may protect against clogged arteries with no risk of excessive bleeding.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hyewon Hyun, MD Po Box 382328, Cambridge, MA 02238-2328 Ph: (617) 661-1949 | Hyewon Hyun, MD 330 Mount Auburn St, Cambridge, MA 02138-5502 Ph: (617) 499-5070 |
News Archive
Reporting in the July 18 issue of The Journal of Experimental Medicine, a group of scientists in Wurzburg, Germany show that the lack of a blood clotting protein may protect against clogged arteries with no risk of excessive bleeding.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.
Probe Manufacturing, Inc., a global electronics design, manufacturing, and services company, is pleased to announce that it has secured a $475,000 blanket purchase order from a medical device manufacturing client with initial delivery starting December of 2010.
People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.
› Verified 5 days ago
Donald Francis Romanelli, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn Street, Mount Auburn Hospital, Cambridge, MA 02138 Phone: 617-492-3500 | |
Dr. Carolyn Lamb, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Wyman 3, Cambridge, MA 02138 Phone: 617-499-5639 Fax: 617-499-5464 | |
Edward B Marianacci, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-499-5070 Fax: 617-499-5138 | |
James J Pollard, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Radiology, Cambridge, MA 02139 Phone: 617-665-1298 | |
Adam F Gustin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Radiology Department, Cambridge, MA 02139 Phone: 617-665-1240 | |
Nazli Erbay, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1599 |